Back to results
US 2003/0148955 A1Published application
Soluble tumor necrosis factor receptor treatment of medical disorders
OwnerJohn D. Pluennekeinventor
Life of this patent
Estimating the term…
Abstract
The invention pertains to methods and compositions for reducing resistance to STI 571 in a chronic myelogenous leukemia patient by administering a TNFα inhibitor, such as recombinant TNFR:Fc to such patient.
Claims10
A method of preventing or reducing resistance to imatinib in a chronic myelogenous leukemia patient comprising administering TNFR:Fc to a chronic myelogenous leukemia patient, wherein said patient is treated concurrently with imatinib.
A method of preventing or reducing resistance to UCN-01 comprising administering TNFR:Fc to a patient having gastrointestinal cancer, wherein said patient is treated concurrently with UCN-01.
Dependencies are inferred from the claim text.